SAMPLE TO OUTCOME Trademark

Trademark Overview


On Tuesday, May 21, 2019, a trademark application was filed for SAMPLE TO OUTCOME with the United States Patent and Trademark Office. The USPTO has given the SAMPLE TO OUTCOME trademark a serial number of 79264602. The federal status of this trademark filing is REGISTERED as of Tuesday, June 30, 2020. This trademark is owned by Qiagen GmbH. The SAMPLE TO OUTCOME trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Medical Instrument Products categories with the following description:

Downloadable and recorded computer software for data and document management, medical teaching; downloadable and recorded computer software and related databases for use in preparing and managing nucleic acid and protein assay analysis and for managing quality control, validation, interpretation, reporting, clinical decision support, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to molecular and genomic analysis; downloadable and recorded computer software, namely, evidence-based decision support software used as an aid in the interpretation of variants observed in genomic sequencing data; downloadable and recorded computer software for evaluation of genomic variants in the context of software for searching and allocating published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and/or clinical-trials; down...

Medical diagnostic testing instruments for processing and analysis of genetic samples primarily for single-cell genomic, transcriptomic, or proteomic analysis; medical and diagnostic apparatus for testing DNA and RNA samples, using gene expression tests, gene expression profiling assays, genetic information and data, protein biomarkers, clinical data, and/or demographic information; testing apparatus for medical purposes for testing DNA and RNA samples sold as a unit with downloadable bioinformatics and machine learning algorithm software and medical data software to support treatment decisions; medical testing apparatus for testing DNA and RNA samples and quantifying biomarker levels and relative expression of host response genes; medical apparatus and instruments for detecting tumor cancer, heredity and genetic diseases; medical testing apparatus for samples of body fluids, tissue and organs; genome machine for medical purposes, namely, apparatus for DNA and RNA medical testing; diag...
sample to outcome

General Information


Serial Number79264602
Word MarkSAMPLE TO OUTCOME
Filing DateTuesday, May 21, 2019
Status700 - REGISTERED
Status DateTuesday, June 30, 2020
Registration Number6087728
Registration DateTuesday, June 30, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements


Goods and ServicesDownloadable and recorded computer software for data and document management, medical teaching; downloadable and recorded computer software and related databases for use in preparing and managing nucleic acid and protein assay analysis and for managing quality control, validation, interpretation, reporting, clinical decision support, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to molecular and genomic analysis; downloadable and recorded computer software, namely, evidence-based decision support software used as an aid in the interpretation of variants observed in genomic sequencing data; downloadable and recorded computer software for evaluation of genomic variants in the context of software for searching and allocating published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and/or clinical-trials; downloadable and recorded computer software for preparing, interpretation and managing of bioinformatics analyses, optionally combined with data management, graphical viewing and output options; downloadable and recorded computer programs and software for biological data mining; downloadable and recorded computer programs and software for developing bioinformatics database for others; bio-chips for research or scientific purposes; DNA-chips; RNA-chips; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer hardware and downloadable and recorded computer software for collecting, storing, analyzing, visualizing, and interpreting bioinformatics, genomics, and phenomics data sets; computer hardware and downloadable and recorded computer software for the monitoring of pathogens; downloadable computer databases for bioinformatics, genomics, phenomics, microbiome, metagenomics, organism-and -pathogen-specific genotype records, and organism and pathogen-specific phenotype information; downloadable and recorded computer software for use in the integration, analysis and visualization of biomedically relevant information allowing users to explore compound, target, assay, biological pathway and disease information; downloadable and recorded computer software and databases for the analysis of genomes, exomes, targeted amplicons, transcriptomes, and epigenetic NGS sequencing data; downloadable and recorded computer software, software development tools, and visualization software modules, for analysis, discovery, verification, and validation of disease biomarkers
Goods and ServicesMedical diagnostic testing instruments for processing and analysis of genetic samples primarily for single-cell genomic, transcriptomic, or proteomic analysis; medical and diagnostic apparatus for testing DNA and RNA samples, using gene expression tests, gene expression profiling assays, genetic information and data, protein biomarkers, clinical data, and/or demographic information; testing apparatus for medical purposes for testing DNA and RNA samples sold as a unit with downloadable bioinformatics and machine learning algorithm software and medical data software to support treatment decisions; medical testing apparatus for testing DNA and RNA samples and quantifying biomarker levels and relative expression of host response genes; medical apparatus and instruments for detecting tumor cancer, heredity and genetic diseases; medical testing apparatus for samples of body fluids, tissue and organs; genome machine for medical purposes, namely, apparatus for DNA and RNA medical testing; diagnostic apparatus for the detection of cancer, genetic or heredity diseases

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, August 16, 2019
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, August 16, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQiagen GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE

Party NameQiagen GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE

Party NameQiagen GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, August 21, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 8, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 16, 2019ASSIGNED TO EXAMINER
Tuesday, August 20, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, August 20, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 4, 2019REFUSAL PROCESSED BY MPU
Wednesday, September 4, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 20, 2019REFUSAL PROCESSED BY IB
Wednesday, March 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 4, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 5, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, September 30, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, October 23, 2020FINAL DISPOSITION PROCESSED
Saturday, October 24, 2020FINAL DISPOSITION NOTICE SENT TO IB
Sunday, January 10, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 30, 2025COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, March 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION